Catalio Strategy
Private Equity
Investing in privately held innovative healthcare companies at all stages, from inception to IPO
Scroll
We focus on category-defining businesses innovating across healthcare x AI: drugs, devices, diagnostics, data, and digital tools that bend the cost curve and redefine patient care.
World-class founders
Investing in innovative companies founded by world-renowned serial entrepreneurs
Transformative technology
Focusing on companies developing drugs, devices, diagnostics, and data at all stages from inception to IPO
Strong IP
Supporting companies with novel solutions to unmet needs
Experienced management
Partnering with companies to recruit seasoned management teams and strong financial syndicates
.svg){kind=logo}
IPO in 2024
Exit in 2019
IPO in 2021
M&A in 2024
IPO in 2020
IPO in 2024
M&A 2025
Loan Repayment in 2024
Exit in 2024
IPO in 2024
Exit in 2023
M&A 2025
IPO in 2024
Exit in 2022
IPO in 2023
Exit in 2021
M&A 2025
Exit in 2022
IPO in 2021
IPO in 2021
IPO in 2024
M&A in 2025
Loan Repayment in 2025
IPO in 2021
M&A 2023
M&A in 2025
Exit in 2020
IPO in 2024
Exit in 2019
IPO in 2021
M&A in 2024
IPO in 2020
IPO in 2024
M&A 2025
Loan Repayment in 2024
Exit in 2024
IPO in 2024
Exit in 2023
M&A 2025
IPO in 2024
Exit in 2022
IPO in 2023
Exit in 2021
M&A 2025
Exit in 2022
IPO in 2021
IPO in 2021
IPO in 2024
M&A in 2025
Loan Repayment in 2025
IPO in 2021
M&A 2023
M&A in 2025
Exit in 2020
